Compound Detail
CHEMBL5083403
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5083403 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | VDEAHPKUJXNLGH-FGZHOGPDSA-N |
5
Targets
9
Activities
3
Assay Types
14
PK Parameters
10
Publications
0
Known Names
Molecular Properties
404.9
MW (Da)
4.26
ALogP
4
HBA
1
HBD
43.4
PSA (Ų)
0.73
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 5 meas. best 4.9
EC50 3 meas. best 9.46
Ki 1 meas. best 9.29
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Mu-type opioid receptor CHEMBL233 | EC50 | 9.46 | 9.0167 | 0.3 | 3 |
| Mu-type opioid receptor CHEMBL233 | Ki | 9.29 | 9.29 | 0.5 | 1 |
| Cytochrome P450 2D6 CHEMBL289 | IC50 | 4.9 | 4.9 | 12700.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 4.64 | 4.64 | 22800.0 | 2 |
| Cytochrome P450 2C19 CHEMBL3622 | IC50 | 4.47 | 4.47 | 33700.0 | 1 |
| Cytochrome P450 3A4 CHEMBL340 | IC50 | 4.39 | 4.39 | 40600.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 131.78 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 134.01 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 176.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 29.2 | mL.min-1.kg-1 | Homo sapiens |
| CL | 152.0 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 62.4 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 622.11 | nM | Rattus norvegicus |
| Fu | 0.34 | - | Homo sapiens |
| Fu | 0.33 | - | Rattus norvegicus |
| Fu | 0.17 | - | Canis lupus familiaris |
| MRT | 0.81 | hr | Rattus norvegicus |
| T1/2 | 1.98 | hr | Rattus norvegicus |
| T1/2 | 0.1194 | hr | - |
| Vd | 10.77 | L.kg-1 | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 34802839 | 10.1016/j.ejmech.2021.113986 | ADMET | 20 |
| 34802839 | 10.1016/j.ejmech.2021.113986 | Mu-type opioid receptor | 6 |
| 34802839 | 10.1016/j.ejmech.2021.113986 | Rattus norvegicus | 3 |
| 34802839 | 10.1016/j.ejmech.2021.113986 | Cytochrome P450 1A2 | 1 |
| 34802839 | 10.1016/j.ejmech.2021.113986 | Cytochrome P450 2C9 | 1 |
| 34802839 | 10.1016/j.ejmech.2021.113986 | Cytochrome P450 2C19 | 1 |
| 34802839 | 10.1016/j.ejmech.2021.113986 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
| 34802839 | 10.1016/j.ejmech.2021.113986 | Delta-type opioid receptor | 1 |
| 34802839 | 10.1016/j.ejmech.2021.113986 | Kappa-type opioid receptor | 1 |
| 34802839 | 10.1016/j.ejmech.2021.113986 | No relevant target | 1 |
Data from ChEMBL 36 via Core Engine